Clinical Trial Update: Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

This document provides a status update on a Phase 2 clinical trial evaluating adavosertib with or without olaparib for recurrent ovarian, fallopian tube, or pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Adavosertib (adavosertib)
• Olaparib (Olaparib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING